Table 1.
Baseline characteristics of the study participants
| Group | Total | Placebo | KRG 1.8 g | KRG 3.6 g |
|---|---|---|---|---|
| Participant, no. (%) | 180 | 60 | 60 | 60 |
| Female sex (%) | 125 (69.4) | 39 (65) | 43 (71.7) | 43 (71.7) |
| Age (yr) | 36.13±11.35 | 37.72±10.88 | 34.88±11.07 | 35.8±0.16 |
| Height (cm) | 165.29±8.18 | 165.51±8.08 | 166.02±8.40 | 164.34±0.73 |
| Body weight (kg) | 59.9±10.03 | 60.87±11.67 | 60.38±11.18 | 58.46±0.81 |
| Body mass index (kg/m2) | 21.92±2.70 | 22.05±2.90 | 21.77±2.88 | 21.95±0.59 |
| Body temperature | 36.75±0.15 | 36.76±0.23 | 36.75±0.20 | 36.73±0.71 |
| Breath (/min) | 17.94±0.42 | 17.92±0.63 | 17.93±0.81 | 17.98±0.87 |
| Heart rate (/min) | 70.08±6.46 | 69.67±7.47 | 69.6±7.87 | 70.98±0.96 |
| Diastolic pressure | 116.98±14.79 | 118.37±8.73 | 117.27±9.54 | 115.3±0.62 |
| Systolic pressure | 72.27±5.4 | 72.2±5.55 | 72.33±6.33 | 72.27±0.89 |
All values are presented as mean ± standard deviation.